Dividend Information About Becton, Dickinson: Everything You Need to Know Before Its Ex-Dividend Date, Sep 8, 2025
Generado por agente de IAAinvest Dividend Digest
jueves, 4 de septiembre de 2025, 10:03 pm ET1 min de lectura
BDX--
Becton, Dickinson and Company (BDX) has announced a cash dividend of $1.04000 per share, with the ex-dividend date set for Sep 8, 2025. The dividend was declared on Jul 22, 2025, and will be paid out on Sep 30, 2025. This payout is significantly higher than the average of the last 10 dividend per share amounts, which stood at approximately $0.30120. The company’s most recent dividend, issued on Jun 30, 2025, was also a cash dividend of $1.04000 per share, indicating a consistent payout pattern in recent months.
Over the past week, BectonBDX--, Dickinson has been the subject of several noteworthy developments. Recently, the company expanded its efforts in peripheral artery disease awareness through its “Love Your Limbs” community screening initiative, launched on Sep 2, 2025. This move highlights BD’s ongoing commitment to public health and community engagement. Additionally, since the last update, the firm has faced some headwinds, as it recently reported revenue that missed expectations in the previous quarter, attributed to softness in its research instrument and diagnostics segments. These challenges underscore the need for continued strategic focus and operational adaptability.
Looking ahead, analysts have indicated that the company is pursuing a forward-looking strategy aimed at driving growth. As of late, BD has outlined a 2025 roadmap that targets revenue growth of 5.5% or more, driven by AI-integrated patient monitoring solutions and innovations in minimally invasive surgical tools. These initiatives align with the growing trend in home healthcare and reflect BD’s strategic pivot to capitalize on emerging market opportunities.
In terms of market performance, BDXBDX-- has shown a mixed technical and fundamental outlook. Over the past week, the stock has experienced a modest increase of +0.78%, although it remains in a weak technical state. This divergence between technical indicators and company fundamentals suggests that investors should proceed with caution and closely monitor the company’s upcoming performance.
In conclusion, Becton, Dickinson continues to demonstrate strategic ambition and operational resilience, even amid recent challenges. The ex-dividend date of Sep 8, 2025, marks the final day for investors to purchase the company’s stock and qualify for the $1.04000 per share dividend. Any shares acquired after this date will not be eligible for the upcoming payout.
Over the past week, BectonBDX--, Dickinson has been the subject of several noteworthy developments. Recently, the company expanded its efforts in peripheral artery disease awareness through its “Love Your Limbs” community screening initiative, launched on Sep 2, 2025. This move highlights BD’s ongoing commitment to public health and community engagement. Additionally, since the last update, the firm has faced some headwinds, as it recently reported revenue that missed expectations in the previous quarter, attributed to softness in its research instrument and diagnostics segments. These challenges underscore the need for continued strategic focus and operational adaptability.
Looking ahead, analysts have indicated that the company is pursuing a forward-looking strategy aimed at driving growth. As of late, BD has outlined a 2025 roadmap that targets revenue growth of 5.5% or more, driven by AI-integrated patient monitoring solutions and innovations in minimally invasive surgical tools. These initiatives align with the growing trend in home healthcare and reflect BD’s strategic pivot to capitalize on emerging market opportunities.
In terms of market performance, BDXBDX-- has shown a mixed technical and fundamental outlook. Over the past week, the stock has experienced a modest increase of +0.78%, although it remains in a weak technical state. This divergence between technical indicators and company fundamentals suggests that investors should proceed with caution and closely monitor the company’s upcoming performance.
In conclusion, Becton, Dickinson continues to demonstrate strategic ambition and operational resilience, even amid recent challenges. The ex-dividend date of Sep 8, 2025, marks the final day for investors to purchase the company’s stock and qualify for the $1.04000 per share dividend. Any shares acquired after this date will not be eligible for the upcoming payout.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios